463
Views
15
CrossRef citations to date
0
Altmetric
Research Article

The Role of the Tec Kinase Bruton's Tyrosine Kinase (Btk) in Leukocyte Recruitment

&
Pages 104-118 | Accepted 20 Feb 2012, Published online: 26 Mar 2012

REFERENCES

  • Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med. 1987;38:175–194.
  • Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006 Mar;6(3):173–182.
  • Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007 Sep;7(9):678–689.
  • Phillipson M, Heit B, Colarusso P, Liu L, Ballantyne CM, Kubes P. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med. 2006 Nov 27;203(12):2569–2575.
  • Zarbock A, Ley K. Protein tyrosine kinases in neutrophil activation and recruitment. Arch Biochem Biophys. 2011 Jun 15;510(2):112–119.
  • Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol. 2010 Feb;38(1):54–60.
  • von Andrian UH, Berger EM, Ramezani L, In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J Clin Invest. 1993 Jun;91(6):2893–2897.
  • Gotsch U, Jager U, Dominis M, Vestweber D. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes Commun. 1994 Apr;2(1):7–14.
  • Kraiss LW, Alto NM, Dixon DA, McIntyre TM, Weyrich AS, Zimmerman GA. Fluid flow regulates E-selectin protein levels in human endothelial cells by inhibiting translation. J Vasc Surg. 2003 Jan;37(1):161–168.
  • Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 1995 May;2(5):493–506.
  • Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996 Nov 1;88(9):3259–3287.
  • von Andrian UH, Hasslen SR, Nelson RD, Erlandsen SL, Butcher EC. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell. 1995 Sep 22;82(6):989–999.
  • Stein JV, Cheng G, Stockton BM, Fors BP, Butcher EC, von Andrian UH. L-selectin-mediated leukocyte adhesion in vivo: microvillous distribution determines tethering efficiency, but not rolling velocity. J Exp Med. 1999 Jan 4;189(1):37–50.
  • Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004;22:129–156.
  • Bargatze RF, Kurk S, Butcher EC, Jutila MA. Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J Exp Med. 1994 Nov 1;180(5):1785–1792.
  • McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997 Dec 1;100(11 Suppl):S97–S103.
  • Mitoma J, Bao X, Petryanik B, Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat Immunol. 2007 Apr;8(4):409–418.
  • Abbal C, Lambelet M, Bertaggia D, Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood. 2006 Nov 15;108(10):3352–3359.
  • Sperandio M, Smith ML, Forlow SB, P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med. 2003 May 19;197(10):1355–1363.
  • Xia L, Sperandio M, Yago T, P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest. 2002 Apr;109(7):939–950.
  • Moore KL, Patel KD, Bruehl RE, P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 1995 Feb;128(4):661–671.
  • Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011 Dec 22;118(26):6743–6751.
  • Crutchfield KL, Shinde Patil VR, Campbell CJ, Parkos CA, Allport JR, Goetz DJ. CD11b/CD18-coated microspheres attach to E-selectin under flow. J Leukoc Biol. 2000 Feb;67(2):196–205.
  • Zen K, Cui LB, Zhang CY, Liu Y. Critical role of mac-1 sialyl lewis x moieties in regulating neutrophil degranulation and transmigration. J Mol Biol. 2007 Nov 16;374(1):54–63.
  • Levinovitz A, Muhlhoff J, Isenmann S, Vestweber D. Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol. 1993 Apr;121(2):449–459.
  • Katayama Y, Hidalgo A, Chang J, Peired A, Frenette PS. CD44 is a physiological E-selectin ligand on neutrophils. J Exp Med. 2005 Apr 18;201(8):1183–1189.
  • Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct. 2002;31:485–516.
  • Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol. 2008 Jan;172(1):1–7.
  • Salas A, Shimaoka M, Kogan AN, Harwood C, von Andrian UH, Springer TA. Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity. 2004 Apr;20(4):393–406.
  • Kuwano Y, Spelten O, Zhang H, Ley K, Zarbock A. Rolling on E- or P-selectin induces the extended but not high-affinity conformation of LFA-1 in neutrophils. Blood. 2010 Jul 29;116(4): 617–624.
  • Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008 Oct;20(5):525–532.
  • Ley K, Baker JB, Cybulsky MI, Gimbrone MA, Jr., Luscinskas FW. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol. 1993 Dec 1;151(11):6347–6357.
  • Zarbock A, Deem TL, Burcin TL, Ley K. Galphai2 is required for chemokine-induced neutrophil arrest. Blood. 2007 Nov 15;110(10):3773–3779.
  • Zarbock A, Lowell CA, Ley K. Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity. 2007 Jun;26(6):773–783.
  • van Kooyk Y, Figdor CG. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol. 2000 Oct;12(5):542–547.
  • Lindbom L, Werr J. Integrin-dependent neutrophil migration in extravascular tissue. Semin Immunol. 2002 Apr;14(2):115–121.
  • Nathan C, Srimal S, Farber C, Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol. 1989 Sep;109(3):1341–1349.
  • Mayadas TN, Cullere X. Neutrophil beta2 integrins: moderators of life or death decisions. Trends Immunol. 2005 Jul;26(7):388–395.
  • Berton G, Lowell CA. Integrin signalling in neutrophils and macrophages. Cell Signal. 1999 Sep;11(9):621–635.
  • Muller WA. Leukocyte–endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 2003 Jun;24(6):327–334.
  • Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev. 2007 Aug;218:178–196.
  • Carman CV, Springer TA. Trans-cellular migration: cell–cell contacts get intimate. Curr Opin Cell Biol. 2008 Oct;20(5):533–540.
  • Carman CV, Sage PT, Sciuto TE, Transcellular diapedesis is initiated by invasive podosomes. Immunity. 2007 Jun;26(6):784–797.
  • Marmon S, Hinchey J, Oh P, Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. Am J Pathol. 2009 Feb;174(2):684–692.
  • Vestweber D, Winderlich M, Cagna G, Nottebaum AF. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 2009 Jan;19(1):8–15.
  • Nourshargh S, Krombach F, Dejana E. The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol. 2006 Oct;80(4):714–718.
  • Vestweber D. Molecular mechanisms that control leukocyte extravasation through endothelial cell contacts. Ernst Schering Found Symp Proc. 2007(3):151–167.
  • Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol. 2004 Oct 25;167(2):377–388.
  • Burns AR, Bowden RA, MacDonell SD, Analysis of tight junctions during neutrophil transendothelial migration. J Cell Sci. 2000 Jan;113 (Pt 1):45–57.
  • Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol. 2006 Feb;8(2):156–162.
  • Shaw SK, Bamba PS, Perkins BN, Luscinskas FW. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol. 2001 Aug 15;167(4):2323–2330.
  • Schulte D, Kuppers V, Dartsch N, Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 2011 Oct 19;30(20):4157–4170.
  • Dangerfield JP, Wang S, Nourshargh S. Blockade of alpha6 integrin inhibits IL-1beta- but not TNF-alpha-induced neutrophil transmigration in vivo. J Leukoc Biol. 2005 Feb;77(2):159–165.
  • Huang MT, Larbi KY, Scheiermann C, ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood. 2006 Jun 15;107(12):4721–4727.
  • Young RE, Thompson RD, Nourshargh S. Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules. Br J Pharmacol. 2002 Dec;137(8):1237–1246.
  • Robinson D, He F, Pretlow T, Kung HJ. A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5958–5962.
  • Yamada N, Kawakami Y, Kimura H, Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun. 1993 Apr 15;192(1):231–240.
  • Tamagnone L, Lahtinen I, Mustonen T, BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene. 1994 Dec;9(12):3683–3688.
  • Tsukada S, Saffran DC, Rawlings DJ, Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993 Jan 29;72(2):279–290.
  • Vetrie D, Vorechovsky I, Sideras P, The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 Jan 21;361(6409):226–233.
  • Rawlings DJ, Saffran DC, Tsukada S, Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993 Jul 16;261(5119):358–361.
  • Siliciano JD, Morrow TA, Desiderio SV. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11194–11198.
  • Heyeck SD, Berg LJ. Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):669–673.
  • Haire RN, Ohta Y, Lewis JE, Fu SM, Kroisel P, Litman GW. TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. Hum Mol Genet. 1994 Jun;3(6):897–901.
  • Hu Q, Davidson D, Schwartzberg PL, Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J Biol Chem. 1995 Jan 27;270(4):1928–1934.
  • Mano H, Ishikawa F, Nishida J, Hirai H, Takaku F. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene. 1990 Dec;5(12):1781–1786.
  • Hirata M, Kanematsu T, Takeuchi H, Yagisawa H. Pleckstrin homology domain as an inositol compound binding module. Jpn J Pharmacol. 1998 Mar;76(3):255–263.
  • Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature. 1997 Jan 2;385(6611):93–97.
  • Schlessinger J. SH2/SH3 signaling proteins. Curr Opin Genet Dev. 1994 Feb;4(1):25–30.
  • Mayer BJ, Gupta R. Functions of SH2 and SH3 domains. Curr Top Microbiol Immunol. 1998;228:1–22.
  • Conley ME. B cells in patients with X-linked agammaglobulinemia. J Immunol. 1985 May;134(5):3070–3074.
  • Campana D, Farrant J, Inamdar N, Webster AD, Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol. 1990 Sep 15;145(6):1675–1680.
  • Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol Cell Biol. 1994 Aug;14(8):5108–5113.
  • Smith CI, Baskin B, Humire-Greiff P, Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol. 1994 Jan 15;152(2):557–565.
  • de Weers M, Verschuren MC, Kraakman ME, The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol. 1993 Dec;23(12):3109–3114.
  • Quek LS, Bolen J, Watson SP. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol. 1998 Oct 8;8(20):1137–1140.
  • Gagliardi MC, Finocchi A, Orlandi P, Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function. Clin Exp Immunol. 2003 Jul;133(1):115–122.
  • Robinson D, Chen HC, Li D, Tyrosine kinase expression profiles of chicken erythro-progenitor cells and oncogene-transformed erythroblasts. J Biomed Sci. 1998;5(2):93–100.
  • Whyatt D, Lindeboom F, Karis A, Ferreira R, Milot E, Hendriks R, An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells. Nature. 2000 Aug 3;406(6795):519–524.
  • Lachance G, Levasseur S, Naccache PH. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils: implication of phosphatidynositol 3-kinases. J Biol Chem. 2002 Jun 14;277(24):21537–21541.
  • Phillips RL, Ernst RE, Brunk B, The genetic program of hematopoietic stem cells. Science. 2000 Jun 2;288(5471):1635–1640.
  • Yang EJ, Yoon JH, Chung KC. Bruton's tyrosine kinase phosphorylates cAMP-responsive element-binding protein at serine 133 during neuronal differentiation in immortalized hippocampal progenitor cells. J Biol Chem. 2004 Jan 16;279(3):1827–1837.
  • Brunner C, Muller B, Wirth T. Bruton's tyrosine kinase is involved in innate and adaptive immunity. Histol Histopathol. 2005 Jul;20(3):945–955.
  • Salim K, Bottomley MJ, Querfurth E, et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 1996 Nov 15;15(22):6241–6250.
  • Rameh LE, Arvidsson A, Carraway KL 3rd, A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem. 1997 Aug 29;272(35):22059–22066.
  • Varnai P, Rother KI, Balla T. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells. J Biol Chem. 1999 Apr 16;274(16):10983–10989.
  • Li T, Rawlings DJ, Park H, Kato RM, Witte ON, Satterthwaite AB. Constitutive membrane association potentiates activation of Bruton tyrosine kinase. Oncogene. 1997 Sep 18;15(12):1375–1383.
  • Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol Cell Biol. 1995 Oct;15(10):5304–5311.
  • Kurosaki T, Kurosaki M. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J Biol Chem. 1997 Jun 20;272(25):15595–15598.
  • Baba Y, Hashimoto S, Matsushita M, BLNK mediates Syk-dependent Btk activation. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2582–2586.
  • Hashimoto S, Iwamatsu A, Ishiai M, Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK—functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood. 1999 Oct 1;94(7):2357–2364.
  • Scharenberg AM, El-Hillal O, Fruman DA, Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 1998 Apr 1;17(7):1961–1972.
  • Kurosaki T. Functional dissection of BCR signaling pathways. Curr Opin Immunol. 2000 Jun;12(3):276–281.
  • Spaargaren M, Beuling EA, Rurup ML, Meijer HP, Klok MD, Middendorp S, The B cell antigen receptor controls integrin activity through Btk and PLCgamma2. J Exp Med. 2003 Nov 17;198(10):1539–1550.
  • Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med. 1991 Mar 1;173(3):599–607.
  • Leuker CE, Labow M, Muller W, Wagner N. Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response. J Exp Med. 2001 Mar 19;193(6):755–768.
  • Arroyo AG, Yang JT, Rayburn H, Hynes RO. Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity. 1999 Nov;11(5):555–566.
  • Arroyo AG, Yang JT, Rayburn H, Hynes RO. Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell. 1996 Jun 28;85(7):997–1008.
  • Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001 Mar 19;193(6):741–754.
  • Berlin-Rufenach C, Otto F, Mathies M, Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med. 1999 May 3;189(9):1467–1478.
  • Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996 Apr 5;272(5258):60–66.
  • Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 2002 Jan;16(1):1–4.
  • Liu YJ, Arpin C. Germinal center development. Immunol Rev. 1997 Apr;156:111–126.
  • MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12:117–139.
  • Lindhout E, Koopman G, Pals ST, de Groot C. Triple check for antigen specificity of B cells during germinal centre reactions. Immunol Today. 1997 Dec;18(12):573–577.
  • Freedman AS, Munro JM, Rice GE, Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science. 1990 Aug 31;249(4972):1030–1033.
  • Koopman G, Parmentier HK, Schuurman HJ, Newman W, Meijer CJ, Pals ST. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med. 1991 Jun 1;173(6):1297–1304.
  • Kosco MH, Pflugfelder E, Gray D. Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J Immunol. 1992 Apr 15;148(8):2331–2339.
  • Cariappa A, Kim TJ, Pillai S. Accelerated emigration of B lymphocytes in the Xid mouse. J Immunol. 1999 Apr 15;162(8):4417–4423.
  • Khan WN, Alt FW, Gerstein RM, Defective B cell development and function in Btk-deficient mice. Immunity. 1995 Sep;3(3):283–299.
  • Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 2000 Jan;12(1):39–49.
  • Buhl AM, Pleiman CM, Rickert RC, Cambier JC. Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J Exp Med. 1997 Dec 1;186(11):1897–1910.
  • Pleiman CM, Hertz WM, Cambier JC. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science. 1994 Mar 18;263(5153):1609–1612.
  • Kurosaki T. Regulation of B-cell signal transduction by adaptor proteins. Nat Rev Immunol. 2002 May;2(5):354–363.
  • Beitz LO, Fruman DA, Kurosaki T, Cantley LC, Scharenberg AM. SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J Biol Chem. 1999 Nov 12;274(46):32662–32666.
  • Craxton A, Jiang A, Kurosaki T, Clark EA. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J Biol Chem. 1999 Oct 22;274(43):30644–30650.
  • Saito K, Tolias KF, Saci A, BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity. 2003 Nov;19(5):669–678.
  • Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol. 2005 Jul;5(7):546–559.
  • Laudanna C, Kim JY, Constantin G, Butcher E. Rapid leukocyte integrin activation by chemokines. Immunol Rev. 2002 Aug;186:37–46.
  • Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity. Immunol Rev. 2003 Oct;195:58–71.
  • Cyster JG. Homing of antibody secreting cells. Immunol Rev. 2003 Aug;194:48–60.
  • Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol. 2005;23:127–159.
  • de Gorter DJ, Beuling EA, Kersseboom R, Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing. Immunity. 2007 Jan;26(1):93–104.
  • Ponader S, Chen SS, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG, Bruton's tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 2012 Feb.2;119(5): 1182–1189.
  • Di Paolo JA, Huang T, Balazs M, Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nat Chem Biol. 2010 Jan;7(1):41–50.
  • Honigberg LA, Smith AM, Sirisawad M, The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075–13080.
  • Gilbert C, Levasseur S, Desaulniers P, Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils, II: effects of LFM-A13, a specific Btk inhibitor. J Immunol. 2003 May 15;170(10):5235–5243.
  • Zen K, Liu Y. Role of different protein tyrosine kinases in fMLP-induced neutrophil transmigration. Immunobiology. 2008;213(1):13–23.
  • Mueller H, Stadtmann A, Van Aken H, Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways. Blood. 2010 Apr 15;115(15):3118–3127.
  • Yago T, Shao B, Miner JJ, E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood. 2010 Jul 22;116(3):485–494.
  • Mahajan S, Ghosh S, Sudbeck EA, Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. J Biol Chem. 1999 Apr 2;274(14):9587–9599.
  • Zarbock A, Abram CL, Hundt M, Altman A, Lowell CA, Ley K. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med. 2008 Sep 29;205(10):2339–2347.
  • Stadtmann A, Brinkhaus L, Mueller H, Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling. Eur J Immunol. 2011 Jul;41(7):2074–2085.
  • Koretzky GA, Abtahian F, Silverman MA. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat Rev Immunol. 2006 Jan;6(1):67–78.
  • Mangla A, Khare A, Vineeth V, Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood. 2004 Aug 15;104(4):1191–1197.
  • Fiedler K, Sindrilaru A, Terszowski G, Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia. Blood. 2010 Jan 27;117(4):1329–1339.
  • Hager M, Cowland JB, Borregaard N. Neutrophil granules in health and disease. J Intern Med. 2010 Jul;268(1):25–34.
  • Buitenhuis M, Verhagen LP, van Deutekom HW, Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis. Blood. 2008 Jan 1;111(1): 112–121.
  • Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood. 1999 Jul 15;94(2):560–571.
  • Kummalue T, Friedman AD. Cross-talk between regulators of myeloid development: C/EBPalpha binds and activates the promoter of the PU.1 gene. J Leukoc Biol. 2003 Sep;74(3):464–470.
  • Yeamans C, Wang D, Paz-Priel I, Torbett BE, Tenen DG, Friedman AD. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood. 2007 Nov 1;110(9):3136–3142.
  • Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005 May 2;201(9):1487–1502.
  • Feldhahn N, Rio P, Soh BN, Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13266–13271.
  • Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis. 1996 Aug;28(2):159–172.
  • Advani R SJ, Smith SM, Effect of Btk inhibitor PCI-32765 monotherapy on responses in patients with relapsed aggressive NHL: evidence of antitumor activity from a phase I study. JCO. 2010;28((15 suppl)):8012.
  • Burger JA OBS, Fowler N, The Bruton's tyrosine kinase inhibitor, PCI-32765, Is well tolerated and demonstrates promising clinical activity in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): an update on ongoing phase 1 studies. Blood. 2010;116(21):32a.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.